Neutrophil-to-Lymphocyte Ratio Is a Major Prognostic Factor in Non-small Cell Lung Carcinoma Patients Undergoing First Line Immunotherapy With Pembrolizumab.
Romano FJ, Ronga R, Ambrosio F, Arundine D, Longo V, Galetta D, Gridelli C, Maione P, Palma V, Damiano V, Verde A, Giacobbe I, Augurio MR, Iengo G, Chetta M, Tarsitano M, Campione S, Failla G, Raucci A, Riccardi F.
Romano FJ, et al. Among authors: iengo g.
Cancer Diagn Progn. 2023 Jan 3;3(1):44-52. doi: 10.21873/cdp.10178. eCollection 2023 Jan-Feb.
Cancer Diagn Progn. 2023.
PMID: 36632583
Free PMC article.